BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND TMPRSS2, PRSS10, 7113, ENSG00000184012, O15393
29 results:

  • 1. DNA Copy Number Alterations and Copy Neutral Loss of Heterozygosity in Adult Ph-Negative Acute B-Lymphoblastic leukemia: Focus on the Genes Involved.
    Risinskaya N; Gladysheva M; Abdulpatakhov A; Chabaeva Y; Surimova V; Aleshina O; Yushkova A; Dubova O; Kapranov N; Galtseva I; Kulikov S; Obukhova T; Sudarikov A; Parovichnikova E
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139431
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Does minimal central nervous system involvement in childhood acute lymphoblastic leukemia increase the risk for central nervous system toxicity?
    Anastasopoulou S; Harila-Saari A; Als-Nielsen B; Eriksson MA; Heyman M; Johannsdottir IM; Marquart HV; Niinimäki R; Pronk CJ; Schmiegelow K; Vaitkeviciene G; Thastrup M; Ranta S
    Pediatr Blood Cancer; 2022 Jul; 69(7):e29745. PubMed ID: 35488712
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Effect of SARS-CoV-2 Entry Factors on Myeloid Cancers.
    Alshareef A
    J Nippon Med Sch; 2022; 89(1):95-101. PubMed ID: 35283406
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Isolation of SARS-CoV-2 in Viral Cell Culture in Immunocompromised Patients With Persistently Positive RT-PCR Results.
    Sung A; Bailey AL; Stewart HB; McDonald D; Wallace MA; Peacock K; Miller C; Reske KA; O'Neil CA; Fraser VJ; Diamond MS; Burnham CD; Babcock HM; Kwon JH
    Front Cell Infect Microbiol; 2022; 12():804175. PubMed ID: 35186791
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Anti-TNF-α agents Modulate SARS-CoV-2 Receptors and Increase the Risk of Infection Through Notch-1 Signaling.
    Keewan E; Beg S; Naser SA
    Front Immunol; 2021; 12():641295. PubMed ID: 34025650
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. COVID‑19 and SARS‑CoV‑2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease.
    Katopodis P; Kerslake R; Davies J; Randeva HS; Chatha K; Hall M; Spandidos DA; Anikin V; Polychronis A; Robertus JL; Kyrou I; Karteris E
    Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33649798
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinically relevant cell culture models and their significance in isolation, pathogenesis, vaccine development, repurposing and screening of new drugs for SARS-CoV-2: a systematic review.
    Kumar S; Sarma P; Kaur H; Prajapat M; Bhattacharyya A; Avti P; Sehkhar N; Kaur H; Bansal S; Mahendiratta S; Mahalmani VM; Singh H; Prakash A; Kuhad A; Medhi B
    Tissue Cell; 2021 Jun; 70():101497. PubMed ID: 33550034
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A meta-analysis of comorbidities in COVID-19: Which diseases increase the susceptibility of SARS-CoV-2 infection?
    Singh MK; Mobeen A; Chandra A; Joshi S; Ramachandran S
    Comput Biol Med; 2021 Mar; 130():104219. PubMed ID: 33486379
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.
    Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Molecular Composition of Genomic
    Krumbholz M; Agaimy A; Stoehr R; Burger M; Wach S; Taubert H; Wullich B; Hartmann A; Metzler M
    Dis Markers; 2019; 2019():5085373. PubMed ID: 31915468
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Bovine leukemia virus linked to breast cancer in Australian women and identified before breast cancer development.
    Buehring GC; Shen H; Schwartz DA; Lawson JS
    PLoS One; 2017; 12(6):e0179367. PubMed ID: 28640828
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Disseminated intravascular coagulation at diagnosis is a strong predictor for thrombosis in acute myeloid leukemia.
    Libourel EJ; Klerk CPW; van Norden Y; de Maat MPM; Kruip MJ; Sonneveld P; Löwenberg B; Leebeek FWG
    Blood; 2016 Oct; 128(14):1854-1861. PubMed ID: 27354723
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Enhancing potency of siRNA targeting fusion genes by optimization outside of target sequence.
    Gavrilov K; Seo YE; Tietjen GT; Cui J; Cheng CJ; Saltzman WM
    Proc Natl Acad Sci U S A; 2015 Dec; 112(48):E6597-605. PubMed ID: 26627251
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. ERG induces a mesenchymal-like state associated with chemoresistance in leukemia cells.
    Mochmann LH; Neumann M; von der Heide EK; Nowak V; Kühl AA; Ortiz-Tanchez J; Bock J; Hofmann WK; Baldus CD
    Oncotarget; 2014 Jan; 5(2):351-62. PubMed ID: 24504051
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Recurrent gene fusions in prostate cancer: their clinical implications and uses.
    Hessels D; Schalken JA
    Curr Urol Rep; 2013 Jun; 14(3):214-22. PubMed ID: 23625457
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Monoallelic expression of tmprss2/ERG in prostate cancer stem cells.
    Polson ES; Lewis JL; Celik H; Mann VM; Stower MJ; Simms MS; Rodrigues G; Collins AT; Maitland NJ
    Nat Commun; 2013; 4():1623. PubMed ID: 23535644
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Recurrent rearrangements in prostate cancer: causes and therapeutic potential.
    White NM; Feng FY; Maher CA
    Curr Drug Targets; 2013 Apr; 14(4):450-9. PubMed ID: 23410129
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Morphologic features of carcinomas with recurrent gene fusions.
    Qi M; Li Y; Liu J; Yang X; Wang L; Zhou Z; Han B
    Adv Anat Pathol; 2012 Nov; 19(6):417-24. PubMed ID: 23060067
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer.
    Brenner JC; Ateeq B; Li Y; Yocum AK; Cao Q; Asangani IA; Patel S; Wang X; Liang H; Yu J; Palanisamy N; Siddiqui J; Yan W; Cao X; Mehra R; Sabolch A; Basrur V; Lonigro RJ; Yang J; Tomlins SA; Maher CA; Elenitoba-Johnson KS; Hussain M; Navone NM; Pienta KJ; Varambally S; Feng FY; Chinnaiyan AM
    Cancer Cell; 2011 May; 19(5):664-78. PubMed ID: 21575865
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Histone deacetylase inhibitors, valproic acid and trichostatin-A induce apoptosis and affect acetylation status of p53 in ERG-positive prostate cancer cells.
    Fortson WS; Kayarthodi S; Fujimura Y; Xu H; Matthews R; Grizzle WE; Rao VN; Bhat GK; Reddy ES
    Int J Oncol; 2011 Jul; 39(1):111-9. PubMed ID: 21519790
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.